HARVARD BIOSCIENCE, INC. Cost of Revenue
HARVARD BIOSCIENCE, INC. (HBIO) reported Cost of Revenue of $10.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $10.10M, a 13.23% increase year-over-year.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $8.51M, a 11.25% decline year-over-year.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $9.56M, a 9.31% decline year-over-year.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $8.57M, a 6.90% decline year-over-year.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for fiscal 2025 was $36.64M, a 6.93% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for fiscal 2024 was $39.37M, a 14.75% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for fiscal 2023 was $46.18M, a 12.07% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. cost of goods and services sold for fiscal 2022 was $52.52M, a 2.47% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.10M 10-Q · filed 2026-08-11 | $18.61M 10-Q · filed 2026-08-11 | $28.17M derived: sum of 3 quarters · filed 2026-08-11 | $36.74M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $8.51M 10-Q · filed 2026-05-12 | $18.07M derived: sum of 2 quarters · filed 2026-05-12 | $26.64M derived: sum of 3 quarters · filed 2026-05-12 | $35.56M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $18.13M derived: sum of 2 quarters · filed 2026-03-13 | $27.05M derived: sum of 3 quarters · filed 2026-08-11 | $36.64M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $8.57M 10-Q · filed 2025-11-06 | $17.49M derived: sum of 2 quarters · filed 2026-08-11 | $27.08M 10-Q · filed 2025-11-06 | $37.62M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $8.92M 10-Q · filed 2026-08-11 | $18.51M 10-Q · filed 2026-08-11 | $29.05M derived: sum of 3 quarters · filed 2026-08-11 | $38.26M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $9.59M 10-Q · filed 2026-05-12 | $20.14M derived: sum of 2 quarters · filed 2026-05-12 | $29.34M derived: sum of 3 quarters · filed 2026-05-12 | $39.22M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $19.75M derived: sum of 2 quarters · filed 2026-03-13 | $29.63M derived: sum of 3 quarters · filed 2026-03-13 | $39.37M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $9.21M 10-Q · filed 2025-11-06 | $19.08M derived: sum of 2 quarters · filed 2025-11-06 | $28.82M 10-Q · filed 2025-11-06 | $40.65M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $9.88M 10-Q · filed 2025-08-11 | $19.62M 10-Q · filed 2025-08-11 | $31.45M derived: sum of 3 quarters · filed 2025-08-11 | $42.08M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $9.74M 10-Q · filed 2025-05-12 | $21.57M derived: sum of 2 quarters · filed 2025-05-12 | $32.20M derived: sum of 3 quarters · filed 2025-05-12 | $44.29M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $11.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $22.46M derived: sum of 2 quarters · filed 2025-03-14 | $34.55M derived: sum of 3 quarters · filed 2025-03-14 | $46.18M 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | $10.64M 10-Q · filed 2024-11-08 | $22.72M derived: sum of 2 quarters · filed 2024-11-08 | $34.35M 10-Q · filed 2024-11-08 | $46.95M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $12.09M 10-Q · filed 2024-08-08 | $23.71M 10-Q · filed 2024-08-08 | $36.31M derived: sum of 3 quarters · filed 2024-08-08 | $51.06M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $11.63M 10-Q · filed 2024-05-07 | $24.22M derived: sum of 2 quarters · filed 2024-05-07 | $38.97M derived: sum of 3 quarters · filed 2024-05-07 | $51.54M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $12.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $27.34M derived: sum of 2 quarters · filed 2024-03-07 | $39.91M derived: sum of 3 quarters · filed 2024-03-07 | $52.52M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $14.75M 10-Q · filed 2023-11-07 | $27.32M derived: sum of 2 quarters · filed 2023-11-07 | $39.92M 10-Q · filed 2023-11-07 | $53.42M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $12.57M 10-Q · filed 2023-08-08 | $25.17M 10-Q · filed 2023-08-08 | $38.67M derived: sum of 3 quarters · filed 2023-08-08 | $52.02M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $12.60M 10-Q · filed 2023-04-26 | $26.10M derived: sum of 2 quarters · filed 2023-04-26 | $39.45M derived: sum of 3 quarters · filed 2023-04-26 | $52.30M derived: sum of 4 quarters · filed 2023-04-26 | ||||
| 2021-12-31 | $13.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $26.85M derived: sum of 2 quarters · filed 2023-03-09 | $39.69M derived: sum of 3 quarters · filed 2023-03-09 | $51.25M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $13.36M 10-Q · filed 2022-11-09 | $26.20M derived: sum of 2 quarters · filed 2022-11-09 | $37.76M 10-Q · filed 2022-11-09 | $51.03M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $12.84M 10-Q · filed 2022-08-04 | $24.40M 10-Q · filed 2022-08-04 | $37.68M derived: sum of 3 quarters · filed 2022-08-04 | $48.22M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $11.56M 10-Q · filed 2022-05-04 | $24.83M derived: sum of 2 quarters · filed 2022-05-04 | $35.38M derived: sum of 3 quarters · filed 2022-05-04 | $44.83M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $13.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $23.82M derived: sum of 2 quarters · filed 2022-03-11 | $33.27M derived: sum of 3 quarters · filed 2022-03-11 | $44.06M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $10.54M 10-Q · filed 2021-11-05 | $19.99M derived: sum of 2 quarters · filed 2021-11-05 | $30.78M 10-Q · filed 2021-11-05 | $44.52M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $9.45M 10-Q · filed 2021-08-06 | $20.24M 10-Q · filed 2021-08-06 | $33.98M derived: sum of 3 quarters · filed 2021-08-06 | $46.42M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $10.79M 10-Q · filed 2021-05-07 | $24.53M derived: sum of 2 quarters · filed 2021-05-07 | $36.97M derived: sum of 3 quarters · filed 2021-05-07 | $50.59M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $13.74M 10-K · filed 2020-03-16 | $26.18M derived: sum of 2 quarters · filed 2020-11-06 | $39.81M derived: sum of 3 quarters · filed 2020-11-06 | $51.85M 10-K/A · filed 2021-03-17 | ||||
| 2019-09-30 | $12.44M 10-Q · filed 2020-11-06 | $26.07M derived: sum of 2 quarters · filed 2020-11-06 | $38.12M 10-Q · filed 2020-11-06 | $53.23M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $13.63M 10-Q · filed 2020-08-10 | $25.68M 10-Q · filed 2020-08-10 | $40.80M derived: sum of 3 quarters · filed 2020-08-10 | $53.61M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $12.05M 10-Q · filed 2020-05-08 | $27.17M derived: sum of 2 quarters · filed 2020-05-08 | $39.98M derived: sum of 3 quarters · filed 2020-05-08 | $56.15M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $15.12M 10-K · filed 2020-03-16 | $27.94M derived: sum of 2 quarters · filed 2020-03-16 | $44.10M derived: sum of 3 quarters · filed 2020-03-16 | $57.59M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $12.82M 10-K · filed 2020-03-16 | $28.98M derived: sum of 2 quarters · filed 2020-03-16 | $42.48M 10-Q · filed 2019-11-08 | $53.10M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $16.17M 10-K · filed 2020-03-16 | $29.66M 10-Q · filed 2019-08-08 | $40.28M derived: sum of 3 quarters · filed 2020-03-16 | $49.50M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | $13.49M 10-K · filed 2020-03-16 | $24.12M derived: sum of 2 quarters · filed 2020-03-16 | $33.33M derived: sum of 3 quarters · filed 2020-03-16 | $43.22M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $10.63M 10-K · filed 2019-03-18 | $14.29M 10-K · filed 2018-03-16 | $19.84M derived: sum of 2 quarters · filed 2019-03-18 | $29.73M derived: sum of 3 quarters · filed 2019-03-18 | $38.24M 10-K · filed 2019-03-18 | $54.28M 10-K · filed 2018-03-16 | ||
| 2017-09-30 | $9.22M 10-K · filed 2019-03-18 | $13.41M 10-Q · filed 2017-11-02 | $19.10M derived: sum of 2 quarters · filed 2019-03-18 | $27.61M 10-Q · filed 2018-11-01 | $39.99M 10-Q · filed 2017-11-02 | $41.92M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $9.88M 10-K · filed 2019-03-18 | $13.93M 10-Q · filed 2017-08-03 | $18.39M 10-Q · filed 2018-08-02 | $26.58M 10-Q · filed 2017-08-03 | $32.70M derived: sum of 3 quarters · filed 2019-03-18 | $46.02M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-03-31 | $8.51M 10-K · filed 2019-03-18 | $12.66M 10-Q · filed 2017-05-08 | $22.82M derived: sum of 2 quarters · filed 2019-03-18 | $36.14M derived: sum of 3 quarters · filed 2019-03-18 | $50.60M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | $14.31M 10-K · filed 2018-03-16 | $27.63M derived: sum of 2 quarters · filed 2018-03-16 | $42.09M derived: sum of 3 quarters · filed 2018-03-16 | $56.11M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $13.32M 10-K · filed 2018-03-16 | $27.78M derived: sum of 2 quarters · filed 2018-03-16 | $41.80M 10-Q · filed 2017-11-02 | $57.24M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $14.46M 10-K · filed 2018-03-16 | $28.48M 10-Q · filed 2017-08-03 | $43.92M derived: sum of 3 quarters · filed 2018-03-16 | $57.93M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $14.02M 10-K · filed 2018-03-16 | $29.46M derived: sum of 2 quarters · filed 2018-03-16 | $43.47M derived: sum of 3 quarters · filed 2018-03-16 | $59.67M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $15.45M 10-K · filed 2017-03-17 | $29.45M derived: sum of 2 quarters · filed 2017-03-17 | $45.66M derived: sum of 3 quarters · filed 2017-03-17 | $59.94M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $14.01M 10-K · filed 2017-03-17 | $30.21M derived: sum of 2 quarters · filed 2017-03-17 | $44.49M 10-Q · filed 2016-11-03 | $61.00M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-06-30 | $16.20M 10-K · filed 2017-03-17 | $30.49M 10-Q · filed 2016-08-04 | $46.99M derived: sum of 3 quarters · filed 2017-03-17 | $61.00M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-03-31 | $14.29M 10-K · filed 2017-03-17 | $30.79M derived: sum of 2 quarters · filed 2017-03-17 | $44.79M derived: sum of 3 quarters · filed 2017-03-17 | $59.47M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2014-12-31 | $16.50M 10-K · filed 2016-04-29 | $30.51M derived: sum of 2 quarters · filed 2016-04-29 | $45.19M derived: sum of 3 quarters · filed 2016-04-29 | $59.32M 10-K · filed 2017-03-17 | ||||
| 2014-09-30 | $14.01M 10-K · filed 2016-04-29 | $28.69M derived: sum of 2 quarters · filed 2016-04-29 | $42.82M 10-Q · filed 2015-11-05 | $58.62M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $14.68M 10-K · filed 2016-04-29 | $28.81M 10-Q · filed 2015-08-06 | $44.62M derived: sum of 3 quarters · filed 2016-04-29 | $58.46M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $14.13M 10-K · filed 2016-04-29 | $29.94M derived: sum of 2 quarters · filed 2016-04-29 | $43.78M derived: sum of 3 quarters · filed 2016-04-29 | $57.78M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $15.81M 10-K · filed 2015-03-12 | $29.64M derived: sum of 2 quarters · filed 2015-03-12 | $43.65M derived: sum of 3 quarters · filed 2015-03-12 | $57.48M 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $13.84M 10-K · filed 2015-03-12 | $13.83M 10-Q · filed 2013-11-08 | $27.84M derived: sum of 2 quarters · filed 2015-03-12 | $41.67M 10-Q · filed 2014-11-06 | $41.65M 10-Q · filed 2013-11-08 | $56.52M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | $14.01M 10-K · filed 2015-03-12 | $14.00M 10-Q · filed 2013-08-09 | $27.83M 10-Q · filed 2014-08-07 | $27.82M 10-Q · filed 2013-08-09 | $42.69M derived: sum of 3 quarters · filed 2015-03-12 | $56.82M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | $13.83M 10-K · filed 2015-03-12 | $13.82M 10-Q · filed 2013-05-10 | $28.68M derived: sum of 2 quarters · filed 2015-03-12 | $42.82M derived: sum of 3 quarters · filed 2015-03-12 | $57.72M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $14.86M 10-K · filed 2014-03-14 | $14.84M 10-K · filed 2013-03-18 | $28.99M derived: sum of 2 quarters · filed 2014-03-14 | $43.89M derived: sum of 3 quarters · filed 2014-03-14 | $58.83M 10-K · filed 2015-03-12 | $58.75M 10-K · filed 2013-03-18 | ||
| 2012-09-30 | $14.13M 10-K · filed 2014-03-14 | $14.11M 10-Q · filed 2012-11-08 | $29.04M derived: sum of 2 quarters · filed 2014-03-14 | $43.91M 10-Q · filed 2013-11-08 | $59.77M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $14.90M 10-K · filed 2014-03-14 | $14.88M 10-Q · filed 2012-08-09 | $29.80M 10-Q · filed 2013-08-09 | $45.64M derived: sum of 3 quarters · filed 2014-03-14 | $60.14M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $14.94M 10-K · filed 2014-03-14 | $14.92M 10-Q · filed 2012-05-10 | $30.74M derived: sum of 2 quarters · filed 2014-03-14 | $45.24M derived: sum of 3 quarters · filed 2014-03-14 | $59.60M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $15.80M 10-K · filed 2013-03-18 | $30.30M derived: sum of 2 quarters · filed 2013-03-18 | $44.66M derived: sum of 3 quarters · filed 2013-03-18 | $58.67M 10-K · filed 2014-03-14 | $58.60M 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $14.50M 10-K · filed 2013-03-18 | $28.86M derived: sum of 2 quarters · filed 2013-03-18 | $42.80M 10-Q · filed 2012-11-08 | $57.92M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $14.36M 10-K · filed 2013-03-18 | $28.30M 10-Q · filed 2012-08-09 | $43.41M derived: sum of 3 quarters · filed 2013-03-18 | $57.30M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $13.94M 10-K · filed 2013-03-18 | $29.06M derived: sum of 2 quarters · filed 2013-03-18 | $42.94M derived: sum of 3 quarters · filed 2013-03-18 | $56.80M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $15.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $29.00M derived: sum of 2 quarters · filed 2013-03-18 | $42.85M derived: sum of 3 quarters · filed 2013-03-18 | $56.37M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $13.89M 10-Q · filed 2011-11-09 | $27.74M derived: sum of 2 quarters · filed 2011-11-09 | $41.26M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $13.86M 10-Q · filed 2011-08-09 | $27.37M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $44.09M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |